Literature DB >> 17009096

Advances in transgenic rat production.

Wanda E Filipiak1, Thomas L Saunders.   

Abstract

Predictable and reproducible production of transgenic rats from a standardized input of egg donors and egg recipients is essential for routine rat model production. In the course of establishing a transgenic rat service, transgenic founders were produced from three transgenes in outbred Sprague-Dawley (SD) rats and four transgenes in inbred Fischer 344 (F344) rats. Key parameters that affect transgenesis efficiency were assessed, including superovulation treatments, methods to prepare pseudopregnant recipients, and microinjection technique. Five superovulation regimens were compared and treatment with 20 IU PMSG and 30 IU HCG was selected for routine use. Four methods to prepare pseudopregnant egg recipients were compared and estrus synchronization with LHRHa and mating to vasectomized males was selected as most effective. More than 80% of eggs survived microinjection when modified pronuclear microinjection needles and DNA buffers were used. The efficiencies of transgenic production in rats and C57BL/6J (B6J) mice were compared to provide a context for assessing the difficulty of transgenic rat production. Compared to B6J mice, SD rat transgenesis required fewer egg donors per founder, fewer pseudopregnant egg recipients per founder, and produced more founders per eggs microinjected. Similar numbers of injection days were required to produce founders. These results suggest that SD rat transgenesis can be more efficient than B6J mouse transgenesis with the appropriate technical refinements. Advances in transgenic rat production have the potential to increase access to rat models.

Entities:  

Mesh:

Year:  2006        PMID: 17009096     DOI: 10.1007/s11248-006-9002-x

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  44 in total

1.  Developing transgenic neuropeptide Y rats.

Authors:  M Michalkiewicz; T Michalkiewicz
Journal:  Methods Mol Biol       Date:  2000

2.  Strain-dependent differences in the efficiency of transgenic mouse production.

Authors:  Anna B Auerbach; Rada Norinsky; Weilan Ho; Kasia Losos; Qiuxia Guo; Samprit Chatterjee; Alexandra L Joyner
Journal:  Transgenic Res       Date:  2003-02       Impact factor: 2.788

3.  Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

Review 4.  Transgenic rats: a discussion.

Authors:  J Heideman
Journal:  Biotechnology       Date:  1991

Review 5.  Lentiviral transgenesis.

Authors:  Alexander Pfeifer
Journal:  Transgenic Res       Date:  2004-12       Impact factor: 2.788

6.  Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1.

Authors:  Freya G G Vercauteren; Stefan Clerens; Line Roy; Nathalie Hamel; Lut Arckens; Frans Vandesande; Leena Alhonen; Juhani Janne; Moshe Szyf; A Claudio Cuello
Journal:  Brain Res Mol Brain Res       Date:  2004-12-20

7.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats.

Authors:  C E Egwuagu; J Sztein; R M Mahdi; W Li; C Chao-Chan; J A Smith; P Charukamnoetkanok; A B Chepelinsky
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

9.  Ketamine/xylazine anesthesia in the pregnant rat.

Authors:  G Stickrod
Journal:  J Am Vet Med Assoc       Date:  1979-11-01       Impact factor: 1.936

Review 10.  Animal models of HLA-B27-associated diseases.

Authors:  Maxime Breban; Cécile Hacquard-Bouder; Géraldine Falgarone
Journal:  Curr Mol Med       Date:  2004-02       Impact factor: 2.222

View more
  40 in total

1.  Efficient mammalian germline transgenesis by cis-enhanced Sleeping Beauty transposition.

Authors:  Daniel F Carlson; Aron M Geurts; John R Garbe; Chang-Won Park; Artur Rangel-Filho; Scott M O'Grady; Howard J Jacob; Clifford J Steer; David A Largaespada; Scott C Fahrenkrug
Journal:  Transgenic Res       Date:  2010-03-30       Impact factor: 2.788

2.  A promoter that drives gene expression preferentially in male transgenic rats.

Authors:  Qiling Li; Yamin Ma; Wenzhi Li; Wei Xu; Li Ma; Guoxing Fu; Xiaohua Tian; Yueling Wang; Xu Li; Tameka Bythwood; Jendai Richards; Mukaila A Akinbami; Qing Song
Journal:  Transgenic Res       Date:  2013-12-15       Impact factor: 2.788

3.  Insertional mutagenesis by a hybrid piggyBac and sleeping beauty transposon in the rat.

Authors:  Kenryo Furushima; Chuan-Wei Jang; Diane W Chen; Ningna Xiao; Paul A Overbeek; Richard R Behringer
Journal:  Genetics       Date:  2012-09-28       Impact factor: 4.562

4.  Inhibition of follicle-stimulating hormone-induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle-stimulating hormone receptor.

Authors:  James A Dias; Brice Campo; Barbara A Weaver; Julie Watts; Kerri Kluetzman; Richard M Thomas; Béatrice Bonnet; Vincent Mutel; Sonia M Poli
Journal:  Biol Reprod       Date:  2014-01-30       Impact factor: 4.285

5.  Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.

Authors:  Steven T Haller; Sivarajan Kumarasamy; David A Folt; Leah M Wuescher; Stanislaw Stepkowski; Manish Karamchandani; Harshal Waghulde; Blair Mell; Muhammad Chaudhry; Kyle Maxwell; Siddhi Upadhyaya; Christopher A Drummond; Jiang Tian; Wanda E Filipiak; Thomas L Saunders; Joseph I Shapiro; Bina Joe; Christopher J Cooper
Journal:  Kidney Int       Date:  2016-09-28       Impact factor: 10.612

6.  The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension.

Authors:  Stephanie W Watts; Emma S Darios; Adam E Mullick; Hannah Garver; Thomas L Saunders; Elizabeth D Hughes; Wanda E Filipiak; Michael G Zeidler; Nichole McMullen; Christopher J Sinal; Ramya K Kumar; David J Ferland; Gregory D Fink
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

7.  Laser-assisted Lentiviral Gene Delivery to Mouse Fertilized Eggs.

Authors:  Negin P Martin; Page Myers; Eugenia Goulding; Shih-Heng Chen; Mitzie Walker; Thomas M Porter; Lucas Van Gorder; Amanda Mathew; Artiom Gruzdev; Erica Scappini; Charles Romeo
Journal:  J Vis Exp       Date:  2018-11-01       Impact factor: 1.355

8.  Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.

Authors:  Hongxia Zhou; Cao Huang; Han Chen; Dian Wang; Carlisle P Landel; Pedro Yuxing Xia; Robert Bowser; Yong-Jian Liu; Xu Gang Xia
Journal:  PLoS Genet       Date:  2010-03-26       Impact factor: 5.917

9.  Efficient activation of reconstructed rat embryos by cyclin-dependent kinase inhibitors.

Authors:  Robin L Webb; Kirk A Findlay; Michael A Green; Tina L Beckett; M Paul Murphy
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

10.  Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.

Authors:  Jason R Cannon; Kindiya D Geghman; Victor Tapias; Thomas Sew; Michelle K Dail; Chenjian Li; J Timothy Greenamyre
Journal:  Exp Neurol       Date:  2012-11-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.